On December 30, 2019 A phase 1 antigen dose escalation trial to evaluate safety, tolerability and immunogenicity of the leprosy vaccine candidate LepVax in healthy adults
On September 9, 2019 A phase 1 study of the safety, reactogenicity, and immunogenicity of a Shicstosoma mansoni vaccine with or without GLA-AF in healthy adults from a non-endemic area
On January 10, 2019 First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Cnadidate to Prevent Pregnancy-associated Malaria
